NCT03813277View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICU

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

May 21, 2018

Study Completion Date

May 21, 2018

Conditions
ICU Sedation
Interventions
DRUG

Dexmedetomidine

infusion

Trial Locations (1)

117997

State Federal-Funded Educational Institution of, Moscow

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03813277 - Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICU | Biotech Hunter | Biotech Hunter